• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Ro 08-2750

CAS No. 37854-59-4

Ro 08-2750 ( —— )

产品货号. M26808 CAS No. 37854-59-4

Ro 08-2750 是一种非肽可逆神经生长因子 (NGF) 抑制剂,可与 NGF 结合,IC50 约为 1 μM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥564 有现货
10MG ¥919 有现货
25MG ¥1803 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥631 有现货

生物学信息

  • 产品名称
    Ro 08-2750
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Ro 08-2750 是一种非肽可逆神经生长因子 (NGF) 抑制剂,可与 NGF 结合,IC50 约为 1 μM。
  • 产品描述
    Ro 08-2750 is a non-peptide and reversible nerve growth factor (NGF) inhibitor which binds to NGF, and with an IC50 of ~ 1 μM. Ro 08-2750 is a selective MSI RNA-binding activity inhibitor, with an IC50 of 2.7 μM. Ro 08-2750 inhibits NGF binding to p75NTR selectively over TRKA.(In Vitro):Ro 08-2750 inhibits the survival of human AML lines and patient cells. Ro 08-2750 suppresses MSI2 RNA-binding and alters the MSI2 gene signature. Ro 08-2750 binds to the NGF dimer thereby probably inducing a change in its conformation such that NGF cannot bind to p75NTR anymore. Ro 08-2750 (5-10 μM; 8?hours) increases differentiation and apoptosis in myeloid leukemia cells. Ro 08-2750 (10 nM) fully rescues cells from undergoing NGF-induced SK-N-MC 103 cell death .(In Vivo):In a myeloid leukemia model in vivo, Ro 08-2750 (13.75?mg/kg; i.p.) suppresses leukemogenesis .
  • 体外实验
    Ro 08-2750 binds to the NGF dimer thereby probably inducing a change in its conformation such that NGF cannot bind to p75NTR anymore.Ro 08-2750 (10 nM) completely rescues cells from undergoing NGF-induced SK-N-MC 103 cells death.Ro 08-2750 (5-10 μM; 8?hours) increases differentiation and apoptosis in myeloid leukemia cells.Ro 08-2750 inhibits survival of human AML lines and patient cells.Ro 08-2750 inhibits MSI2 RNA-binding and alters MSI2 gene signature. Apoptosis Analysis Cell Line:MLL-AF9?+?BM cells Concentration:5?μM, 10?μM Incubation Time:8?hours Result:Increased apoptosis.
  • 体内实验
    Ro 08-2750 (13.75mg/kg; i.p.) inhibits leukemogenesis in a myeloid leukemia model in vivo. Animal Model:C57BL/6 wild type mice (10-12-weeks-old), MLL-AF9 murine leukemia model Dosage:13.75?mg/kg Administration:Intraperitoneal injection, at days 1, 4, 7, 10, and 13 (one day on, two days off drug)Result:Inhibited c-MYC levels and reduced disease burden.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    AhR| Androgen Receptor| Antifungal| Estrogen Receptor/ERR
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    37854-59-4
  • 分子量
    270.248
  • 分子式
    C13H10N4O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 4 mg/mL (14.80 mM)
  • SMILES
    Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C)c2cc1C=O
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Liu J, et al. Whole transcriptome analysis of Penicillium digitatum strains treatmented with prochloraz reveals their drug-resistant mechanisms. BMC Genomics. 2015 Oct 24;16:855.
产品手册
关联产品
  • Milatuzumab

    Milatuzumab (hLL1; MEDI-115) 是一种人源化抗 CD74 单克隆抗体。CD74 是一种完整的膜蛋白,与促进 B 细胞生长和存活有关。Milatuzumab 导致自由基氧的产生和线粒体膜电位的丧失。 Milatuzumaba 还降低 CD20/CD74 聚集体和细胞粘附,从而导致细胞死亡。

  • HCV Core Protein (19...

    PQDVKFP 是一个合成肽,可识别丙型肝炎病毒 (HCV) 核心蛋白的抗原域。

  • PCLX-001

    PCLX-001 是一种具有口服活性的小分子 N- 肉豆蔻转移酶 (NMT) 抑制剂,对 NMT1 和 NMT2 的 IC50 分别为 5 nM 和 8 nM。PCLX-001 具有抗癌活性、抑制早期 B 细胞受体 (BCR) 信号,可用于对恶性淋巴瘤的研究。